HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liquid-holding experiments with human peripheral lymphocytes. II. Experiments with trenimon and 1-beta-D-arabinosylcytosine.

Abstract
Liquid holding of trenimon-treated human peripheral lymphocytes in the G0 stage of the cell cycle leads to an elevation in the frequencies of chromosome aberrations and a decrease in the frequencies of chromatid aberrations. The frequencies of aberrant metaphases are not influenced significantly under these experimental conditions. Storage of trenimon-treated cells in the presence of 1-beta-D-arabinosylcytosine (araC) leads to an additional increase in the frequencies of chromosome-type aberrations, with an increase in the frequencies of aberrant metaphases as well. These findings are interpreted as DNA double-strand breaks being formed during the repair of damaged DNA, and that araC exaggerates this effect by inhibiting repair. AraC does not influence the frequencies of SCEs significantly, which indicates that either the lesions or the repair pathways leading to chromosome aberrations are different from those leading to SCEs.
AuthorsS Kalweit, G Obe
JournalMutation research (Mutat Res) Vol. 128 Issue 1 Pg. 59-64 (Aug 1984) ISSN: 0027-5107 [Print] Netherlands
PMID6472307 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytarabine
  • Triaziquone
Topics
  • Cells, Cultured
  • Chromosome Aberrations
  • Crossing Over, Genetic (drug effects)
  • Cytarabine (pharmacology)
  • DNA Repair (drug effects)
  • Humans
  • Lymphocytes (drug effects)
  • Sister Chromatid Exchange (drug effects)
  • Triaziquone (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: